Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $111.62 | $25.54 | 337.12% | 210.60x | 53.12x | 14.16x | 17.10x | 1.53x | $106.92M | 0.91% | $705.78M | 6.70 | $11.96B | 1,525.09 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $23.90 | $8.69 | 175.18% | 113.81x | 55.58x | 6.72x | 13.62x | 0.98x | $39.15M | 1.26% | $220.58M | 1.69 | $3.08B | 67.93 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $77.91 | $18.40 | 323.50% | 72.81x | 66.65x | 7.19x | 9.29x | 1.86x | $182.84M | 3.03% | $654.15M | 8.43 | $5.91B | 49.29 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $266.11 | $84.22 | 215.98% | 43.62x | 39.23x | 7.40x | 26.30x | 1.54x | $793.95M | 2.23% | $1.35B | 10.14 | $36.89B | 31.28 | ||
| RPRX | ROYALTY PHARMA PLC | $63.96 | $38.25 | 67.22% | 34.02x | 11.94x | 11.22x | 3.76x | 0.69x | $2.92B | 10.27% | $9.79B | 21.99 | $44.93B | 38.20 | ||
| VCEL | VERICEL CORP | $40.19 | $8.49 | 373.27% | 83.73x | 71.81x | 6.70x | 5.56x | 2.05x | $61.66M | 3.00% | $370.04M | 7.25 | $2.03B | 45.98 | ||
| HALO | HALOZYME THERAPEUTICS INC | $110.19 | $72.12 | 52.80% | 30.95x | 12.20x | 7.77x | 87.13x | 0.63x | $806.22M | 6.24% | $143.54M | 1.22 | $14.49B | 20.17 | ||
| KRYS | KRYSTAL BIOTECH INC | $358.24 | $89.53 | 300.13% | 43.32x | 45.90x | 24.02x | 7.80x | 2.30x | $257.78M | 2.44% | $1.36B | 46.03 | $10.18B | 43.66 | ||
| TGTX | TG THERAPEUTICS INC | $55.99 | $23.81 | 135.10% | 18.18x | 56.33x | 9.93x | 14.19x | 2.02x | $17.39M | 0.22% | $604.08M | 4.26 | $8.84B | 63.49 | ||
| TECH | BIO-TECHNE CORP | $72.43 | $17.40 | 316.18% | 61.91x | 34.69x | 9.30x | 5.39x | 1.95x | $263.22M | 2.33% | $2.11B | 13.52 | $11.38B | 32.74 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.40 | $8.08 | 53.38% | 13.05x | 11.40x | 5.39x | 3.38x | 1.14x | $82.01M | 11.18% | $217.65M | 3.68 | $592.53M | 7.66 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $66.53 | $20.01 | 232.54% | 175.08x | 22.85x | 3.78x | 2.04x | 1.15x | $738.18M | 5.74% | $6.32B | 32.68 | $16.19B | 41.98 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $246.81 | $189.07 | 30.54% | 16.17x | 9.66x | 3.39x | 3.34x | 0.68x | $1.62B | 10.38% | $4.80B | 75.98 | $18.80B | 11.63 | ||
| ADMA | ADMA BIOLOGICS INC | $9.62 | $7.41 | 29.79% | 13.36x | 12.09x | 4.29x | 5.28x | 0.78x | $116.47M | 5.30% | $408.21M | 1.79 | $2.22B | 9.51 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $546.12 | $161.65 | 237.85% | 31.51x | 28.41x | 11.01x | 6.84x | 2.24x | $3.80B | 2.74% | $20.25B | 79.81 | $134.25B | 24.40 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.21 | $6.31 | -80.83% | 8.64x | -4.09x | 1.49x | 1.59x | 0.07x | $19.58M | 27.93% | $44.20M | 0.76 | $21.73M | 2.84 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $285.60 | $91.28 | 212.88% | 28.36x | 30.23x | 19.72x | 5.88x | 2.14x | $130.62M | 2.28% | $967.52M | 48.22 | $5.82B | 20.86 | ||
| MDXG | MIMEDX GROUP INC | $4.57 | $1.51 | 201.84% | 114.25x | -32.57x | 1.90x | 3.08x | 1.09x | $44.50M | 6.59% | $216.00M | 1.46 | $547.49M | 24.00 | ||
| EXEL | EXELIXIS INC | $59.01 | $31.83 | 85.41% | 17.94x | 17.87x | 6.08x | 7.93x | 1.18x | $1.17B | 7.92% | $1.84B | 7.35 | $14.51B | 13.34 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $42.25 | $31.97 | 32.17% | 13.46x | 10.14x | 2.55x | 2.46x | 0.80x | $354.90M | 14.50% | $999.24M | 17.25 | $2.06B | 7.37 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $827.72 | $453.11 | 82.67% | 19.74x | 14.84x | 5.48x | 2.69x | 1.05x | $3.76B | 4.42% | $31.71B | 308.48 | $85.47B | 14.86 | ||
| UTHR | UNITED THERAPEUTICS CORP | $487.61 | $203.49 | 139.62% | 16.12x | 18.20x | 6.58x | 3.27x | 2.79x | $1.09B | 5.26% | $6.40B | 150.24 | $19.11B | 11.40 | ||
| INCY | INCYTE CORP | $126.75 | $62.57 | 102.56% | 15.61x | 35.75x | 4.36x | 4.05x | 1.75x | $1.92B | 7.56% | $6.34B | 31.66 | $21.74B | 10.51 | ||
| VCYT | VERACYTE INC | $42.53 | $7.19 | 491.28% | 29.53x | 40.68x | 6.05x | 2.46x | 117.47x | $165.99M | 4.88% | $1.39B | 17.36 | $3.16B | 22.61 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.